This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1991 Jul 9;199(3):389-91.

doi: 10.1016/0014-2999(91)90508-n.

Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys

J R Taylor¹, M S Lawrence, D E Redmond Jr, J D Elsworth, R H Roth, D E Nichols, R B Mailman

Affiliations

PMID: 1680717
DOI: 10.1016/0014-2999(91)90508-n

Free article

Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys

J R Taylor et al. Eur J Pharmacol. 1991.

Free article

. 1991 Jul 9;199(3):389-91.

doi: 10.1016/0014-2999(91)90508-n.

Authors

J R Taylor¹, M S Lawrence, D E Redmond Jr, J D Elsworth, R H Roth, D E Nichols, R B Mailman

Affiliation

¹ Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510.

PMID: 1680717
DOI: 10.1016/0014-2999(91)90508-n

No abstract available

PubMed Disclaimer

Similar articles

The effects of D1 and D2 dopamine receptor agonist and antagonist on parkinsonism in chronic MPTP-treated monkeys.
Nomoto M, Fukuda T. Nomoto M, et al. Adv Neurol. 1993;60:119-22. Adv Neurol. 1993. PMID: 8093574 No abstract available.
Effects of dihydrexidine, a full dopamine D-1 receptor agonist, on delayed response performance in chronic low dose MPTP-treated monkeys.
Schneider JS, Sun ZQ, Roeltgen DP. Schneider JS, et al. Brain Res. 1994 Nov 7;663(1):140-4. doi: 10.1016/0006-8993(94)90471-5. Brain Res. 1994. PMID: 7850462
Dihydrexidine, a full D1 dopamine receptor agonist, induces rotational asymmetry in hemiparkinsonian monkeys.
Johnson BJ, Peacock V, Schneider JS. Johnson BJ, et al. Pharmacol Biochem Behav. 1995 Aug;51(4):617-22. doi: 10.1016/0091-3057(94)00424-h. Pharmacol Biochem Behav. 1995. PMID: 7675833
[Mechanism of induction of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin].
Hirata Y, Nagatsu T. Hirata Y, et al. Tanpakushitsu Kakusan Koso. 1986 Apr;31(5):398-409. Tanpakushitsu Kakusan Koso. 1986. PMID: 3520683 Review. Japanese. No abstract available.
[Significance of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine for the etiology and therapy of idiopathic Parkinson disease].
Lange KW. Lange KW. Fortschr Neurol Psychiatr. 1989 Apr;57(4):142-8. doi: 10.1055/s-2007-1000755. Fortschr Neurol Psychiatr. 1989. PMID: 2656447 Review. German.

See all similar articles

Cited by

The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease.
Scheller D, Ullmer C, Berkels R, Gwarek M, Lübbert H. Scheller D, et al. Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):73-86. doi: 10.1007/s00210-008-0341-4. Epub 2008 Aug 14. Naunyn Schmiedebergs Arch Pharmacol. 2009. PMID: 18704368
Dopamine D₁ Agonists: First Potential Treatment for Late-Stage Parkinson's Disease.
Lewis MM, Van Scoy LJ, De Jesus S, Hakun JG, Eslinger PJ, Fernandez-Mendoza J, Kong L, Yang Y, Snyder BL, Loktionova N, Duvvuri S, Gray DL, Huang X, Mailman RB. Lewis MM, et al. Biomolecules. 2023 May 12;13(5):829. doi: 10.3390/biom13050829. Biomolecules. 2023. PMID: 37238699 Free PMC article. Clinical Trial.
Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys.
Arnsten AF, Cai JX, Murphy BL, Goldman-Rakic PS. Arnsten AF, et al. Psychopharmacology (Berl). 1994 Oct;116(2):143-51. doi: 10.1007/BF02245056. Psychopharmacology (Berl). 1994. PMID: 7862943
Morphine and naltrexone modulate D2 but not D1 receptor induced motor behavior in MPTP-lesioned monkeys.
Vermeulen RJ, Drukarch B, Sahadat MC, Goosen C, Schoffelmeer AN, Wolters EC, Stoof JC. Vermeulen RJ, et al. Psychopharmacology (Berl). 1995 Apr;118(4):451-9. doi: 10.1007/BF02245946. Psychopharmacology (Berl). 1995. PMID: 7568632
Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines.
Cueva JP, Chemel BR, Juncosa JI Jr, Lill MA, Watts VJ, Nichols DE. Cueva JP, et al. Eur J Med Chem. 2012 Feb;48:97-107. doi: 10.1016/j.ejmech.2011.11.039. Epub 2011 Dec 3. Eur J Med Chem. 2012. PMID: 22204903 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

Grants and funding

etc

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database